Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha
- PMID: 2143102
- PMCID: PMC11038898
- DOI: 10.1007/BF01789178
Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha
Abstract
We recently reported that interleukin-2(IL-2)-activated peripheral blood lymphocytes and CD3+, lymphokine-activated killer (LAK) cell clones release tumor necrosis factor alpha(TNF alpha) and interferon gamma (IFN gamma) when stimulated with K562 erythroleukemia cells. We examined the phenotype of IL-2-activated peripheral blood leukocytes that secrete TNF alpha and IFN gamma when stimulated with K562 cells and demonstrated that TNF alpha secretion is not due to the presence of contaminating mononuclear phagocytes. Further, we demonstrate that IL-2-activated natural killer (NK) cells release only IFN gamma when stimulated with K562 cells while T lymphocytes exposed to monoclonal anti-CD3 and K562 cells secrete both TNF alpha and IFN gamma. However, T cells stimulated only with K562 cells did not release IFN gamma or TNF alpha while the admixture of these T cells with NK cells, when stimulated with K562 cells, released levels of TNF alpha comparable to those produced by the unseparated cells. At present it is unclear whether only one or both effector cell types respond to K562 by releasing TNF alpha or why the presence both cell types is needed.
Similar articles
-
Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.Cancer Immunol Immunother. 1992;35(5):335-41. doi: 10.1007/BF01741147. Cancer Immunol Immunother. 1992. PMID: 1382856 Free PMC article.
-
Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.Cell Immunol. 1992 Oct 1;144(1):69-79. doi: 10.1016/0008-8749(92)90226-f. Cell Immunol. 1992. PMID: 1356634
-
Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.Cancer Immunol Immunother. 1989;29(4):270-8. doi: 10.1007/BF00199215. Cancer Immunol Immunother. 1989. PMID: 2502310 Free PMC article.
-
Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-gamma and tumor necrosis factor-alpha.Cell Immunol. 1991 Apr 15;134(1):96-110. doi: 10.1016/0008-8749(91)90334-8. Cell Immunol. 1991. PMID: 1901521
-
The regulation and biological activity of interleukin 12.Leuk Lymphoma. 1998 May;29(5-6):427-38. doi: 10.3109/10428199809050903. Leuk Lymphoma. 1998. PMID: 9643557 Review.
Cited by
-
Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma.Cancer Immunol Immunother. 1992;35(5):335-41. doi: 10.1007/BF01741147. Cancer Immunol Immunother. 1992. PMID: 1382856 Free PMC article.
-
Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.J Clin Immunol. 1996 Jan;16(1):46-54. doi: 10.1007/BF01540972. J Clin Immunol. 1996. PMID: 8926285
-
ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells.Cancer Immunol Immunother. 1994 Aug;39(2):127-34. doi: 10.1007/BF01525318. Cancer Immunol Immunother. 1994. PMID: 7519126 Free PMC article.
-
Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients.Clin Exp Immunol. 1994 Jun;96(3):484-90. doi: 10.1111/j.1365-2249.1994.tb06055.x. Clin Exp Immunol. 1994. PMID: 8004819 Free PMC article.
References
-
- Chong AS-F, Aleksijevic A, Scuderi P, Hersh EM, Grimes WJ. Phenotypic and functional analysis of lymphokine activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets. Cancer Immunol Immunother. 1989;29:270. - PMC - PubMed
-
- Chong AS-F, Scuderi P, Grimes WJ, Hersh EM. Tumor targets stimulate IL-2 activated killer cells to produce interferongamma and tumor necrosis factor. J Immunol. 1989;142:2133. - PubMed
-
- DeVita VT, Hellman S, Rosenberg SA. Cancer principles and practice of oncology, vol 1. 2nd edn. Philadelphia: Lippincott; 1989. p. 301.
-
- Djeu JY, Blanchard DK, Richards AL, Friedman H. Tumor necrosis factor induction byCandida albicans from natural killer cells and monocytes. J Immunol. 1988;141:4047. - PubMed
-
- Fiers W, Bronckaert P, Devos R, Fransen L, Haeg G, Leroux-Roels G, Marmenont A, Remant E, Suffys P, Tavernier J, van der Heyden J, von Roy F. Molecular and cellular biology of tumor necrosis factor, interferon gamma and their synergism. In: Cantell K, Schellekens H, editors. The biology of the interferon system. Dordrecht: Nijnhoff; 1986. p. 205.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources